A comprehensive view of Cedars-Sinai. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Cedars-Sinai develops new nanotechnology-based ‘liquid biopsy’ test that can detect and profile prostate cancers, even in microscopic amounts; fast, minimally invasive, cost-effective test could direct cancer patients to effective therapies

Cedars-Sinai launches new division of Population Sciences Research; division to conduct intervention trials to reduce the risk of disease, address health disparities, translate research into actionable information that closes healthcare gaps

Cell therapy developed at Cedars-Sinai delays disease progression in Duchenne muscular dystrophy patients who have few treatment options; treatment uses cardiosphere heart muscle cells to improve heart, skeletal muscle function, blunt inflammation

Nearly 75% of people prefer annual fecal immunochemical tests over colonoscopy every 10 years for colorectal cancer screening; educating people about testing options may persuade more people to get screenings: Cedars-Sinai

COVID-19 vaccination appears to strengthened T-cell immune response in inflammatory bowel disease patients taking anti-tumor necrosis factor drug therapy; association reported between biologic drugs, reduced hospitalizations, deaths from COVID-19: study

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count